Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features.
Cancer Cell Int. 2022 Sep 20;22(1):289. doi: 10.1186/s12935-022-02713-9.
Cancer Cell Int. 2022.
PMID: 36127671
Free PMC article.
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells.
Park S, Kim YJ, Park JM, Park M, Nam KD, Farrand L, Nguyen CT, La MT, Ann J, Lee J, Kim JY, Seo JH.
Park S, et al.
Cell Death Discov. 2021 Nov 13;7(1):354. doi: 10.1038/s41420-021-00743-2.
Cell Death Discov. 2021.
PMID: 34775489
Free PMC article.
Item in Clipboard
Cite
Cite